|
Re: ASCo report--the more things change, the more things change
It seems to me it is better than NOT biopsying.
FYI when they look at circulating tumor cells in metastatic bc patients, they find all kinds of combinations floating around, not just those the patients are being treated for ie, triple negative CTCs in her2+ Stage IV patients being treated with herceptin
|